Similarly in humans, adiponectin levels are reduced in individuals with obesity and diabetes across all age groups, whereas increased adiponectin is linked to improved insulin resistance (180-186). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.